Zobrazeno 1 - 10
of 52
pro vyhledávání: '"J C TRENT"'
Autor:
J. C. Trent, Robert S. Benjamin, Judy Garber, A. G. Dumont, Joseph A. Ludwig, Vinod Ravi, Sara S. Strom, S. Patel, R. K. Pandurengan, Dejka M. Araujo
Publikováno v:
Annals of Oncology. 21:2107-2111
Gastrointestinal stromal tumor (GIST) is a rare cancer of the digestive tract that accounts for 0.1%–3.0% of all gastrointestinal neoplasms, 10% of small-bowel tumors, and 10%–15% of all sarcomas [1–4]. There are ∼5000 newly diagnosed cases p
Autor:
Adel K. El Naggar, Jennifer J. Wheler, Lei Ye, John J. Wright, Razelle Kurzrock, Aung Naing, Chaan S. Ng, Rabia Khan, Steven I. Sherman, Said M. Sebti, Nizar M. Tannir, Robert F. Gagel, Robert A. Newman, Stacy L. Moulder, Michelle A. Blaskovich, David S. Hong, J. C. Trent
Publikováno v:
Clinical Cancer Research. 15:7061-7068
Purpose: We evaluated the safety, maximum tolerated dose, pharmacokinetics, and biological effects of the combination of the Raf-1, RET, KIT, platelet-derived growth factor receptor, and vascular endothelial growth factor receptor 2 kinase inhibitor
Autor:
Marc K. Halushka, Juan Carlos Plana, J. C. Trent, Courtney L. Bickford, Daniel J. Lenihan, Jean-Bernard Durand, Christos M. Kassiotis, Nizar M. Tannir, J. Chris Champion, Aarif Y. Khakoo
Publikováno v:
Cancer. 112:2500-2508
Background Sunitinib malate is a novel multitargeted receptor tyrosine kinase inhibitor with established efficacy in the treatment of metastatic renal cell carcinoma and imatinib-resistant gastrointestinal stromal tumor. This report describes the dev
Autor:
Sebastian Bauer, J. C. Trent, Florence Duffaud, J.-Y. Blay, U. Bitz, Michael Montemurro, Hans Gelderblom, Daniel Pink, Jochen Schütte, Heikki Joensuu, Piotr Rutkowski
Publikováno v:
European Journal of Cancer, 49(5), 1027-1031
Background Tyrosine kinase inhibitors (TKI) improve the outcome of patients with advanced gastrointestinal stromal tumour (GIST), but treatment failure is frequent, and prognosis then bleak. Smaller trials in this setting suggested activity for soraf
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f9c0c44f0b1528fe8da2540611b5a5fa
https://hdl.handle.net/1887/100095
https://hdl.handle.net/1887/100095
Autor:
A. G. Dumont, Markku Miettinen, Alexander J. Lazar, J. C. Trent, Brian P. Rubin, Robert G. Maki, Lori Rink, Jonathan R. Strosberg, Dina Lev, Andrew K. Godwin, Alessandro Gronchi, David Goldstein, Christopher L. Corless, Heikki Joensuu, M. von Mehren
BACKGROUND: Gastrointestinal stromal tumors (GISTs) and desmoid tumors (DTs) are two rare mesenchymal tumor. Anecdotal reports of individuals with both diseases led us to make the hypothesis that the association is a nonrandom event as the probabilit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::487865f89302502309fc477617c2d602
https://europepmc.org/articles/PMC3493136/
https://europepmc.org/articles/PMC3493136/
Autor:
J. C. Trent, Charles D. Blanke, Joel Picus, Peter W.T. Pisters, A. Sirulnik, E. Stealey, M. von Mehren
Publikováno v:
Annals of oncology : official journal of the European Society for Medical Oncology. 22(11)
Background The objective of the study was to describe patterns of care of patients with gastrointestinal stromal tumors (GISTs) in the United States in the tyrosine kinase inhibitor (TKI) era. Patients and methods From November 2004 through March 200
Autor:
J C, TRENT
Publikováno v:
Archives of surgery (Chicago, Ill. : 1920). 51
Autor:
J C, TRENT
Publikováno v:
The Surgical clinics of North America. 26
Autor:
J C, TRENT
Publikováno v:
North Carolina medical journal. 7
Autor:
J C, TRENT
Publikováno v:
Surgery, gynecologyobstetrics. 82